Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Sep 2, 2015 at 1:50 PM EDT

Tesaro Rises on Positive FDA Results

Tesaro shares reacted positively in the market Wednesday after positive study results surrounding its lead product were released.

Chris Lange | Sep 2, 2015 at 10:50 AM EDT

What to Expect From Medtronic Earnings

Medtronic is scheduled to report its fiscal first-quarter financial results on Thursday after the markets close.

Chris Lange | Sep 2, 2015 at 10:15 AM EDT

Heartware Moves to Acquire Valtech Cardio

Heartware International is looking to continue its strong performance in 2015, and one of the better options that the company…

Chris Lange | Sep 1, 2015 at 1:55 PM EDT

Is the Move in Trevena Sustainable?

Trevena saw its shares continue to climb during Tuesday’s session on news of a positive Phase 2 trial.

Chris Lange | Sep 1, 2015 at 12:05 PM EDT

Cortendo Prepares for IPO

Cortendo has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Sep 1, 2015 at 11:05 AM EDT

PharMEDium Files for IPO

PharMEDium Healthcare Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Sep 1, 2015 at 10:20 AM EDT

NovoCure Gears Up for IPO

NovoCure Ltd. Has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Sep 1, 2015 at 9:55 AM EDT

Sancilio Pharma Files for IPO

Sancilio Pharmaceuticals has with the Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Trey Thoelcke | Sep 1, 2015 at 7:35 AM EDT

What Illumina Gets With GenoLogics Life Science Software

Tuesday morning, Illumina announced the completion of its acquisition of GenoLogics Life Science Software.

Chris Lange | Aug 31, 2015 at 4:34 PM EDT

Trevena Soars on Positive Phase 2 Results

Trevena watched its shares soar in Monday’s after-hours session on news of a positive Phase 2 trial.

Chris Lange | Aug 31, 2015 at 4:08 PM EDT

Is the BioLife Move Sustainable?

BioLife Solutions was up solidly in Monday’s trading session on positive results from a Phase 3 study.

Chris Lange | Aug 31, 2015 at 1:55 PM EDT

Why Recent IPO Aimmune Therapeutics Could Rise 50% to 100%

24/7 Wall St. has chosen two key analysts to highlight that have issued calls on Aimmune.

Chris Lange | Aug 31, 2015 at 11:25 AM EDT

Is the Move in Vital Therapies Sustainable?

Vital Therapies made a big run in the market on Monday morning following additional data from the 16th International Symposium…

Chris Lange | Aug 31, 2015 at 9:15 AM EDT

The Medicines Company and Alnylam Rise on Positive Phase 1 Results

Alnylam Pharmaceuticals and The Medicines Company made waves Monday morning despite downward pressure from the broad markets.

Paul Ausick | Aug 31, 2015 at 7:35 AM EDT

Canadian Cannabis Firms Close Merger

Tweed Marijuana announced Monday morning that the company had completed its merger with Bedrocan Cannabis.

1 … 247 248 249 250 251 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Tesaro Rises on Positive FDA Results

What to Expect From Medtronic Earnings

Heartware Moves to Acquire Valtech Cardio

Is the Move in Trevena Sustainable?

Cortendo Prepares for IPO

PharMEDium Files for IPO

NovoCure Gears Up for IPO

Sancilio Pharma Files for IPO

What Illumina Gets With GenoLogics Life Science Software

Trevena Soars on Positive Phase 2 Results

Is the BioLife Move Sustainable?

Why Recent IPO Aimmune Therapeutics Could Rise 50% to 100%

Is the Move in Vital Therapies Sustainable?

The Medicines Company and Alnylam Rise on Positive Phase 1 Results

Canadian Cannabis Firms Close Merger

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Apple Might Haven Taken Aim at OpenAI with New Announcement. There’s Only One Problem.

Warren Buffett’s $400 Billion Is Going Nowhere for Now: Here’s Why Berkshire Hathaway Is My Top Pick for the Next 20 Years

Why One AI Giant Is Paying ~2.2X per GPU More Than What Anthropic Pays SpaceX

Retiring at the Coast Comes With a $9,800 Annual Insurance Shock

How a 401(k) Balance Over $1 Million Quietly Pushes 85 Percent of a Couple's Social Security Into the Taxable Zone

Trump and Warsh Plot Chaotic Stock Market Strategy for June

Apple Might Haven Taken Aim at OpenAI with New Announcement. There’s Only One Problem.

Health and Healthcare Articles

All Health and Healthcare Articles

Tesaro Rises on Positive FDA Results

What to Expect From Medtronic Earnings

Heartware Moves to Acquire Valtech Cardio

Is the Move in Trevena Sustainable?

Cortendo Prepares for IPO

PharMEDium Files for IPO

NovoCure Gears Up for IPO

Sancilio Pharma Files for IPO

What Illumina Gets With GenoLogics Life Science Software

Trevena Soars on Positive Phase 2 Results

Is the BioLife Move Sustainable?

Why Recent IPO Aimmune Therapeutics Could Rise 50% to 100%

Is the Move in Vital Therapies Sustainable?

The Medicines Company and Alnylam Rise on Positive Phase 1 Results

Canadian Cannabis Firms Close Merger

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Apple Might Haven Taken Aim at OpenAI with New Announcement. There’s Only One Problem.

Warren Buffett’s $400 Billion Is Going Nowhere for Now: Here’s Why Berkshire Hathaway Is My Top Pick for the Next 20 Years

Why One AI Giant Is Paying ~2.2X per GPU More Than What Anthropic Pays SpaceX

Featured Reads

Retiring at the Coast Comes With a $9,800 Annual Insurance Shock

How a 401(k) Balance Over $1 Million Quietly Pushes 85 Percent of a Couple's Social Security Into the Taxable Zone